Live News Categoriesmarket

SPARC (SPARC) News

Follow SPARC (SPARC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SPARC Asset market Sector Markets 90 days 1 Updated Sep 10, 2026, 05:41 AM UTC Open live news feed

L Eris, Torrent Pharma, Natco, Lupin stand out in Rs157 billion India GLP-1 opportunity: Kotak Eris Lifesciences, Torrent Pharma, Natco Pharma and Lupin are expected to see the highest contribution to FY2029E earnings per share from India's GLP-1 opportunity, at 4-12%, according to Kotak Institutional Equities. Su EARNINGS | Sep 10, 2026, 05:41 AM UTC